Taylor Forte
About Taylor Forte
Taylor Forte serves as the Associate Director of Process Development at Sana Biotechnology, Inc., where she focuses on upstream process development for monoclonal antibodies and stem cell-derived therapies. She holds a Bachelor of Science in Biology and Mathematics from Emory University and has a diverse background in engineering roles at Biogen and other companies.
Current Role at Sana Biotechnology
Taylor Forte serves as the Associate Director of Process Development at Sana Biotechnology, Inc. since 2023. In this role, Forte is involved in the stem cell differentiation process for a Beta cell therapy program. The focus of this position is on advancing therapeutic solutions through innovative process development strategies.
Previous Experience at Biogen
Prior to joining Sana Biotechnology, Forte worked at Biogen for a total of four years. Starting as Engineer I from 2017 to 2019, Forte progressed to Engineer II from 2019 to 2021, and then to Engineer III from 2021 to 2022. This experience provided a solid foundation in engineering within the biotechnology sector.
Educational Background
Forte earned a Bachelor of Science (B.S.) in Biology and Mathematics from Emory University, studying from 2013 to 2017. This educational background supports Forte's expertise in process development and engineering within the biotechnology field.
Early Career and Internships
Before establishing a career in biotechnology, Forte held various positions that contributed to professional development. This includes serving as a Bioassays Intern at Regeneron Pharmaceuticals, Inc. in 2016, and working as an Office Assistant at Charter Brokerage LLC from 2012 to 2013. Additionally, Forte gained leadership experience as a Coach/Manager for Harlem RBI in 2013.
Expertise in Process Development
Forte has developed expertise in upstream process development for monoclonal antibodies (mAbs) and stem cell-derived therapies. This specialization is critical for advancing therapeutic applications in biotechnology, particularly in the context of innovative treatment solutions.